Concentra Group Holdings Bolsa (NYSE: CON)

Concentra Group Holdings (NYSE:CON) Bolsa

Concentra Group Holdings

Concentra Group Holdings Parent Inc is a company providing occupational and consumer health services through occupational health centers and onsite clinics. Their services include workers' compensation injury care, employer services, urgent care, clinical testing, wellness programs, and preventative care.

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

IMAC Holdings sube más del 108% tras anunciar Ignite Proteomics. Conoce las acciones más destacadas en la negociación previa.

Acciones de IMAC Holdings se disparan un 108%; 20 acciones en movimiento en el premercado de EE.UU.

Concentra Group Holdings Parent, Inc. Common Stock

Concentra Group Holdings Parent Inc

CONUN

Conectisys Corp

GraniteShares 1x Short COIN Daily ETF

CELLTRION INC ORD by Celltrion, Inc.

GraniteShares 2x Long COIN Daily ETF

CoinSmart Financial Inc

Conn's Inc

Convergence

NICKEL 28 CAP CORP by NICKEL 28 CAP CORP.

Nickel 28 Capital Corp

CONX Corp Units (1 Ord Share Class A & 1/4 War)

CONX Corp

Tidal ETF Trust II YieldMax COIN Option Income Strategy ETF

Shares of Target Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) were trading lower on Tuesday, after the company reported <a href="https://www.benzinga.com/25/03/44106754/targets-q4-earnings-beat-estimates-warns-consumer-uncertainty-impact-in-q1-profits">its fourth-quarter results</a>.
The results came in amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Telsey Advisory Group On Target
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e301e08430dee0001c88c8d/joseph-feldman">Analyst Joseph Feldman</a> reiterated an Outperform rating and price target of $150.
Target reported its fourth-quarter earnings at $2.41 per share, beating consensus of $2.26 per share, with in-line comps and better-than-expected operating margins, Feldman said in a note. Although traffic grew 2.1% during the quarter, the impact was partly offset by a 0.6% decline in average ticket, he added.
Target's operating margins contracted by 110 basis points to 4.7%, while gross margins declined by 36 basis points to 26.2%, "reflecting higher digital fulfillment and supply chain costs as well as elevated promotions and clearance rates," the analyst wrote. The company expects its profits to be under "meaningful pressure" in the first quarter, "given a softer start to February, uncertainty related to consumer spending trends and potential tariffs," he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Roth Capital Partners On Target
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e00db2d3513fb0001f048a6/bill-kirk">Analyst Bill Kirk</a> maintained a Neutral rating and price target of $131.
Target guided to fiscal 2025 net sales growth of around 1%, below consensus of 3%, and flat comp store sales, versus consensus of 1.6%, Kirk said. The company's guidance "suggests the macro environment does not improve," he added.
"Importantly, the year has started below the guided plan, with February experiencing a small net sales decline," the analyst wrote. The sales decline in February could exert "meaningful" pressure on Target's profits in the first quarter, which means the company would need to improve its business to achieve the fiscal 2025 guided ranges, he further stated.
JPMorgan On Target
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/584847d9ee7bf6000154d225/christopher-horvers">Analyst Christopher Horvers</a> reaffirmed a Neutral rating on the stock.
Target reported fourth-quarter comps of 1.5%, in-line with expectations, with strong traffic and digital performance, Horvers said. However, the company expects its comps to be roughly flat on net sales growth around 1%, he added.
Management guided earnings from $8.80 per share to $9.80 per share, "implying low 5% op margin at the midpoint," the analyst stated. The company indicated that "ongoing consumer uncertainty, a weak February, the timing of certain costs, and tariff uncertainty are expected to create meaningful YOY profit pressure in 1Q vs. the remainder of FY25," he further wrote.
TGT Price Action: Shares of Target were down 5.7% to $113.84 at the time of publication on Tuesday.
Read More:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43875446/walmarts-ai-use-cases-surge-amid-strong-q4-even-as-company-forecasts-weaker-2026">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings Beats

Reiteration

Analyst Ratings

Movers

Trading Ideas

Target Q4 Beats Expectations, Analysts See Profit Pressure Ahead

<a href="https://x.com/i/broadcasts/1mrxmPXMOQMJy" title="https://x.com/i/broadcasts/1mrxmPXMOQMJy">https://x.com/i/broadcasts/1mrxmPXMOQMJy</a>

Macro Economic Events

News

Politics

Global

Economics

General

Canada's Trudeau Says He Expects To Speak With President Trump In The Days To Come

Dan&nbsp;Loeb‘s&nbsp;Third Point LLC has gradually reduced its stake in tech giant Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) over the last year, lowering the stake by 3x since <a target="_blank" href="https://www.benzinga.com/topic/dan-loeb" rel="noreferrer noopener">the fourth quarter of 2023</a>.
Details: According to recent 13F filings, reflecting his holding as of Dec. 31, 2024, Loeb slashed his stake in the company from 870,000 shares <a href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624005927/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">in </a>the third quarter of 2024 <a href="https://www.sec.gov/Archives/edgar/data/1040273/000108514625001713/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">to </a>600,000. That&#8217;s a decline of around 31%.
This compares to 1.58 million shares <a href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624004004/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">as </a>of the second quarter of 2024, 1.765 million shares <a href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624002645/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">as </a>of the first quarter of 2024, and 2.015 million shares as <a href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624001503/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">of </a>the fourth quarter of 2023.
<ul>
<li>In January, Microsoft&nbsp;reported second-quarter&nbsp;EPS of&nbsp;$3.23, beating the&nbsp;$3.11&nbsp;consensus estimate, and revenue of&nbsp;$69.6 billion, beating the&nbsp;<a href="https://www.benzinga.com//node/43320124" target="_blank" rel="noreferrer noopener">$68.78 billion&nbsp;analyst consensus estimate</a>.</li>
<li>The company revealed transformative momentum in its artificial intelligence business, announcing a&nbsp;$13 billion&nbsp;annual AI revenue run rate alongside a major Azure commitment from&nbsp;OpenAI&nbsp;that propelled commercial bookings to unprecedented&nbsp;<a href="https://www.benzinga.com//node/43327008" target="_blank" rel="noreferrer noopener">levels in the&nbsp;second quarter</a>.</li>
<li>In February, the company has&nbsp;began canceling leases&nbsp;for significant data center capacity in the U.S., possibly <a href="https://www.benzinga.com/25/02/43917474/microsoft-cancels-major-data-center-leases-raises-questions-on-ai-expansion-strategy" target="_blank" rel="noreferrer noopener">signifying AI computing overcapacity</a>.</li>
<li>CEO Satya Nadella unveiled Majorana 1, a quantum chip powered by an entirely new state of matter—topoconductorsn and aims to scale to 1 million qubits <a href="https://www.benzinga.com/25/02/43830761/microsoft-unveils-majorana-1-quantum-chip-races-against-google-and-nvidia-in-quantum-computing" target="_blank" rel="noreferrer noopener">for industrial-scale problem-solving</a>.</li>
<li>Microsoft has pledged to invest an additional $700 million in Poland. The investment aims to strengthen the country's cybersecurity infrastructure in partnership <a href="https://www.benzinga.com/25/02/43764792/microsoft-commits-700-million-to-boost-polands-cybersecurity-infrastructure-as-part-of-the-2023-polish-data-center-project" target="_blank" rel="noreferrer noopener">with the Polish armed forces</a>.</li>
<li>In March, the company launched Dragon Copilot, an AI assistant designed to streamline clinical workflows by combining voice dictation, ambient&nbsp;<a href="https://www.benzinga.com/25/03/44087329/microsoft-unveils-ai-powered-dragon-copilot-to-ease-clinician-workloads" target="_blank" rel="noreferrer noopener">listening, and generative AI</a>.</li>
</ul>
<h2 class="wp-block-heading">Analysts Views</h2>
<ul>
<li>Morgan Stanley analyst Keith Weiss lowered the price forecast from $540 to $530, stating that while &#8221;Azure was disappointing.&#8221; Strength in the GenAI ramp vs moderating capex growth should <a href="https://www.benzinga.com//node/43351098" target="_blank" rel="noreferrer noopener">support accelerating FY26 FCF growth</a>.</li>
<li>DA Davidson determined that demand for its AI services &#8221;remains heightened.&#8221; However, core Azure services continue to decelerate. Management is retracting its previous guidance of a &#8221;second-<a href="https://www.benzinga.com/quote/MSFT/analyst-ratings" target="_blank" rel="noreferrer noopener">half reacceleration of Azure revenue</a>.&#8221;</li>
<li>Raymond James analyst says that overall, this quarter will &#8221;go down as a disappointment.&#8221; That&#8217;s not due to any revisions on the scale of the AI opportunity but more due to the timing of capitalization on these trends.</li>
</ul>
In the past year, Microsoft has declined around 3.5%, underperforming the iShares U.S. Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYW#NYSE">IYW</a>), which gained about 43.1% over the same time frame.
Also, the company significantly lagged compared to its closest peers Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), which rose roughly 46.0%, and&nbsp;ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), which grew approximately 22.99% in the last one year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/02/43945075/dan-loeb-adjusts-healthcare-holdings-danaher-stake-trimmed-as-thermo-fisher-gains-favor" target="_blank" rel="noreferrer noopener">Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

iShares Dow Jones US Technology Sector Index Fund

MSFT

ORCL

Dan Loeb's Third Point Slashes Microsoft Stake, Analysts Blame 'Disappointing' Azure

On Tuesday, the FDA accepted for review Capricor Therapeutics Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) Biologics License Application for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44104490/capricor-therapeutics-announces-fda-acceptance-and-priority-review-of-its-biologics-license-applic" rel="noreferrer noopener">(DMD) cardiomyopathy.</a>
DMD cardiomyopathy is a heart condition characterized by cardiac fibrosis, arrhythmias, and heart failure.&nbsp;
Additionally, the FDA granted the BLA Priority Review with a Prescription Drug User Fee Act (PDUFA) target action date of August 31, 2025.
The FDA has not identified any potential review issues.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41294970/capricor-therapeutics-says-duchenne-muscular-dystrophy-candidate-shows-sustained-cardiac-skeletal" rel="noreferrer noopener">Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years</a>
The BLA submission is supported by Capricor&#8217;s existing cardiac data from its Phase 2 HOPE-2 and HOPE-2 Open Label Extension (OLE) trials compared to natural history data.
The FDA also informed the company that they have not yet decided whether an Advisory Committee meeting is needed regarding this application.
Deramiocel for DMD has received&nbsp;Orphan Drug Designation&nbsp;from the FDA and European Medicines Agency.
In addition, if Capricor were to receive FDA marketing approval for deramiocel regarding the treatment of DMD by September 30, 2026, Capricor would be eligible to receive a Priority Review Voucher based on its previous receipt of a rare pediatric disease designation.
Price Action: CAPR stock is up 6.33% at $14.54 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44113171/agentexchange-salesforces-new-ai-marketplace-targets-6-trillion-digital-labor-market" target="_blank" rel="noreferrer noopener">AgentExchange: Salesforce&#8217;s New AI Marketplace Targets $6 Trillion Digital Labor Market</a></li>
</ul>

Biotech

Health Care

CAPR

Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition

Canada's Trudeau Says Will Find New Ways To Cooperate With Mexico To Deal With The Tariffs

WIIM

TVGN

Tevogen Bio Holdings shares are trading higher after D. Boral Capital initiated coverage on the stock with a Buy rating and announced a $10 price target.

EKSO

Ekso Bionics Holdings shares are trading lower after the company reported mixed Q4 financial results.

AT&T CEO Expects Business Wireline Segment To Be Successful

Canada's Trudeau Addressing President Trump, Says 'This Is A Very Dumb Thing To Do'; Tells Canadians 'this Is Going To Be Tough', Will Offer More Supports To Canadian Workers And Businesses; Says We Will Take Measures To Prevent Predatory Behavior That Threatens Canadian Companies

Canada's Trudeau Says Canada Will Be Imposing 25% Tariffs On U.S. Imports Worth C$30 Billion With Immediate Effect; Canada Will Impose 25% Tariffs On A Further C$125 Billion Of U.S. Imports In 21 Days' Time; Canada Will Challenge U.S. Tariffs Through WTO And USMCA; If U.S. Tariffs Persist, Canada Will Also Look At Non-Tariff Measures, Does Not Give Details; Says U.S. Government Has Chosen To Put American Jobs At Risk, 'There Is Absolutely No Justification Or Need Whatsoever For These Tariffs Today'

In the current session, McGrath RentCorp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGRC#NASDAQ">MGRC</a>) is trading at $118.80, after a 0.72% drop. Over the past month, the stock decreased by 3.91%, and in the past year, by 3.76%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1741104947_0.png" alt="Past Year Chart" />

<h3>McGrath RentCorp P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 82.58 in the Trading Companies &amp; Distributors industry, McGrath RentCorp Inc. has a lower P/E ratio of 12.69. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1741104947_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

MGRC

Price Over Earnings Overview: McGrath RentCorp

There's been a lot of buzz about the Great Wealth Transfer—<a href="https://www.ubs.com/content/dam/assets/wm/global/insights/doc/global-wealth-report.pdf?campID=UC:E:601227:601243:275609551:0:1662290115:1661963018:en:665757016:::">an estimated $84 trillion</a> set to move from Baby Boomers to younger generations over the next two decades. But is it really the financial windfall some are expecting? Experts say poor estate planning, shifting economic realities, and <a href="https://www.benzinga.com/personal-finance/25/02/43420405/which-executive-order-lowers-prices-cbs-host-brennan-grills-jd-vance-on-trumps-economic-promises">rising costs</a> could mean that this transfer isn't as life-changing as it seems.
<h2 class="wp-block-heading">The Great Wealth Transfer: What's Really Happening?</h2>
For starters, a huge chunk of people aren't prepared for this shift. A<a href="https://trustandwill.com/learn/estate-planning-report-2025"> report by Trust &amp; Will</a> found that while 83% of Americans believe estate planning is important, only 31% have a will, and just 11% have a trust. Worse, 55% have no estate documents at all, leaving heirs to deal with probate, legal fees, and potential family disputes.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>
That sounds messy, but some experts aren't too worried. Some experts say that wealth often transfers informally—through gifts, shared assets, and financial support—rather than one big inheritance.
<a href="https://iariw.org/wp-content/uploads/2024/08/IARIW_Sabelhaus-2.pdf">A 2024 IARIW study</a> using SCF data revealed nearly $900 billion in 2021 wealth transfers (inheritances and inter vivos transfers). Inter vivos transfers made significantly exceeded reported inter vivos transfers received, indicating potential underreporting of received inter vivos transfers. In other words, not every family needs a formal trust to pass down money.
Meanwhile, generational wealth is already shifting. A<a href="https://kpmg.com/au/en/home/media/press-releases/2025/01/the-great-wealth-transfer-begins-as-gen-x-overtake-boomers.html"> report from KPMG</a> shows that Gen X (born 1965–1980) now holds more property and stock wealth than Boomers. The average Gen X homeowner has $1.31 million in housing wealth, just above Boomers at $1.30 million. In stock investments, Gen X holds about $256,000, compared to Boomers' $206,000.
Trending: <a href="https://www.benzinga.com/money/arrived-centennial">Jeff Bezos-Backed Arrived Homes Hits A Big Sale On Charlotte Property – Investors Earning A 34.7% Return</a>
Still, some worry that Millennials and Gen Z won't see the same financial success. <a href="https://educationdata.org/student-loan-debt-by-generation">Student debt</a>, high living costs, and stagnant wages as potential barriers, even if these generations inherit money.
Looking at the numbers, this shift is massive. <a href="https://www.cerulli.com/press-releases/cerulli-anticipates-124-trillion-in-wealth-will-transfer-through-2048">Cerulli Associates</a> estimates that by 2048, $124 trillion will change hands—$105 trillion to heirs and $18 trillion to charities. The wealthiest 2% will transfer over $62 trillion.
But will it really reshape the economy? Boston College law professor Ray Madoff argues that most of this wealth stays within wealthy families, meaning it won't necessarily reduce economic inequality.
And here's the reality check: many people may not inherit as much as they expect. A&nbsp; <a href="https://news.northwesternmutual.com/2024-08-06-As-90-Trillion-Great-Wealth-Transfer-Approaches,-Just-1-in-4-Americans-Expect-to-Leave-an-Inheritance">Northwestern Mutual study</a> found that only 22% of Boomers and Gen X plan to leave behind large financial gifts. Rising<a href="https://www.benzinga.com/startups/25/02/43662970/mark-cuban-says-u-s-healthcare-is-horrific-calls-for-free-medical-school-to-fix-doctor-shortages-and-soaring-costs"> healthcare</a> costs, longer life expectancy, and potential tax changes could eat into inheritances.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/if-you-invested-in-nvidia-in-2022">Here&#8217;s how much you should have invested in Nvidia in 2022 to become a millionaire today</a>.</li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

People Spend $12K on Trusts—Then Forget To Fund Them: The Costly Estate Planning Mistake That Lands Families in Probate

Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) has outperformed the market over the past 5 years by 16.35% on an annualized basis producing an average annual return of 32.27%. Currently, Spotify Technology has a market capitalization of $115.85 billion. 
Buying $1000 In SPOT: If an investor had bought $1000 of SPOT stock 5 years ago, it would be worth $3,899.06 today based on a price of $565.91 for SPOT at the time of writing.
<h3>Spotify Technology's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741104914_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPOT

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Following the announcement of a <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44077079/analysts-doubt-us-crypto-reserve-expansion-beyond-bitcoin-cite-funding-challenges">strategic crypto stockpile</a> containing altcoins, several cabinet members of the Trump administration have drawn scrutiny for their crypto holdings.
What Happened: In an X <a href="https://x.com/PelosiTracker_/status/1896691911802622115">post</a> on Tuesday, market commentator &#8216;The Pelosi Tracker&#8217; noted that Trump's proposed crypto strategic reserve has sparked debate, as several of his cabinet members hold substantial crypto assets.
His son, Eric Trump, has indirect exposure through the World Liberty Financial project, which reportedly purchased $47 million in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and $45 million in Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>). 
Bill Pulte, nominee for Director of Federal Housing Finance, owns up to $1 million in Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and Bitcoin, plus $25 million in Bitcoin mining stock Marathon Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>).
Kash Patel, nominee for FBI director, has a spouse with $100,000 in Grayscale's Bitcoin ETF. 
Robert Kennedy Jr., appointed as HHS Director, holds $1.3 million in Bitcoin and previously pledged to divest if confirmed.
Michael Kratsios, nominee for the Office of Science and Technology Policy, owns $250,000 in Bitcoin and $50,000 in Ethereum. 
Vice President JD Vance reportedly had up to $500,000 in Bitcoin, though his current holdings remain unclear.
While Tulsi Gabbard previously owned crypto, she pledged to divest before her confirmation and appears to have followed through. 
Notably absent from holdings are Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>). 
GOP Representative Guy Reschenthaler (R-PA) made history as the first-ever congressional member to purchase $15,000 worth of XRP in mid-January.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44106531/eric-trump-said-buy-the-dips-in-february-but-peter-schiff-isnt-buying-the-genius-bitcoin-xrp-cardano-strategic-reserve-announcement">Eric Trump Said &#8216;Buy The Dips&#8217; In February, But Peter Schiff Isn&#8217;t Buying The &#8216;Genius&#8217; Bitcoin, XRP, Cardano Strategic Reserve Announcement</a>
Why It Matters: While many cabinet members hold crypto ETFs, launching a crypto strategic reserve would directly benefit those with exposure to specific assets.
Arkham Intelligence <a href="https://intel.arkm.com/explorer/entity/donald-trump">data</a> suggests Donald Trump himself holds a $1.8 million crypto portfolio, including Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>), USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>), Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), Maga (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MAGA</a>) and other smaller coins.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/25/03/44107003/trump-faces-backlash-over-crypto-reserve-plan-from-bitcoin-supporters-including-his-own-dont-think-the-government-should-be-pumping-our-crypto-bags-with-taxpayer-money">Trump&#8217;s Crypto Reserve Plan Sparks Backlash From Fans For Adding Ether, XRP, Solana, Cardano: &#8216;Don&#8217;t Think The Government Should Be Pumping Our Crypto Bags With Taxpayer Money&#8217;</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$BTC

$DOGE

$ETH

$MAGA

$MATIC

$SOL

$TRUMP

$USDC

$XRP

MARA

Trump's Cabinet Holds Bitcoin, Solana, Ethereum—But No Cardano Or XRP

<a href="https://www.gevernova.com/news/press-releases/ge-vernova-aws-accelerate-global-energy-demand">https://www.gevernova.com/news/press-releases/ge-vernova-aws-accelerate-global-energy-demand</a>
&nbsp;
GE Vernova to support AWS data center scaling with Electrification technologies and Consulting Services
GE Vernova to support AWS's commitment to achieve net-zero carbon emissions by 2040
AWS to support GE Vernova's cloud migration and digital innovation goals, including GenAI
CAMBRIDGE, Mass.&nbsp;(March 4, 2025)&nbsp;–&nbsp;<a href="https://www.gevernova.com/">GE Vernova</a> Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) and Amazon Web Services, Inc (AWS), an Amazon.com, Inc. company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>),&nbsp;today announced the signing of a strategic framework agreement (SFA) aimed at supporting AWS's data center scaling, and collaborating to address increasing global energy demand, advance grid security and reliability, and decarbonize electric power systems.
Through this collaboration, GE Vernova will provide AWS with new offerings across a broad scope of solutions to electrify and decarbonize data centers across North America, Europe, and Asia, including:
<ul>
<li>Electrification Systems: GE Vernova will continue to provide AWS with turnkey substation solutions to enable connectivity of AWS data centers to the grid, including expansion of major electrical equipment, project management, and construction support, across multiple sites globally. AWS and GE Vernova engineering teams will continue to work together to optimize data center substation design and delivery.</li>
<li>Renewables: GE Vernova will collaborate with AWS to enhance the path for commercializing onshore wind development projects.</li>
<li>Power Generation, Innovation and Services: GE Vernova and AWS will also explore additional opportunities for GE Vernova to provide power generation equipment and services to AWS as well as work with GE Vernova's accelerator businesses – Advanced Research, Consulting Services, and Financial Services – to advance energy transition innovation, research, project development, and financing.</li>
</ul>

Contracts

AMZN

GE Vernova And AWS Expand Collaboration To Address Accelerating Global Energy Demand Through Strategic Framework Agreement; No Financial Terms Disclosed

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Biohaven (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>) with a Buy and maintains $54 price target.

Price Target

BHVN

HC Wainwright & Co. Reiterates Buy on Biohaven, Maintains $54 Price Target

<a href="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12239455?requestToken=eyJzdWIiOiI0NjBkZDYwNS1iN2ExLTQwNWMtYmQxYS05YTljOGFlN2NjNzEiLCJ2ZXIiOiIxNzllODU5Ni0zMWNjLTQwMjMtOTQzMS1kNGQwOGQwMDQxZjAiLCJleHAiOjB9" title="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12239455?requestToken=eyJzdWIiOiI0NjBkZDYwNS1iN2ExLTQwNWMtYmQxYS05YTljOGFlN2NjNzEiLCJ2ZXIiOiIxNzllODU5Ni0zMWNjLTQwMjMtOTQzMS1kNGQwOGQwMDQxZjAiLCJleHAiOjB9">https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12239455?requestToken=eyJzdWIiOiI0NjBkZDYwNS1iN2ExLTQwNWMtYmQxYS05YTljOGFlN2NjNzEiLCJ2ZXIiOiIxNzllODU5Ni0zMWNjLTQwMjMtOTQzMS1kNGQwOGQwMDQxZjAiLCJleHAiOjB9</a>

ACON

Aclarion Awarded Patent No. US 12239455 B2 Titled "MAGNETIC RESONANCE SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAIN OR INFECTION ASSOCIATED WITH PROPIONIC ACID"

W&T Offshore shares are trading lower after the company reported worse-than-expected Q4 financial results.

U.S. stocks were trading lower on Tuesday following the <a href="https://www.benzinga.com/25/03/44103406/us-stocks-futures-tumble-as-traders-await-trumps-congress-address-volatility-is-certainly-being-fed-by-trump-20-moves-says-expert">worst trading session of 2025</a>, as investor anxiety over impending tariffs weighed on sentiment. President Donald Trump stated Monday that negotiations with Canada and Mexico had reached an impasse ahead of Tuesday&#8217;s tariff deadline.
Treasury yields also declined, with the 10-year yield at 4.16%, while markets overwhelmingly expect the <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44108079/no-bidders-no-safety-net-is-feds-liquidity-lifeline-drying-up-plus-etfs-to-watch">Federal Reserve</a> to hold interest rates steady in March.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44108913/tariffs-trump-tumult-how-to-trade-this-volatility-vix-surge">Tariffs, Trump, Tumult: How To Trade The Volatility Surge</a>
What Historical Data Says: Monday's market drop saw steep declines in the technology, energy and consumer discretionary sectors, making it the second-worst trading day of March on record.
However, per research from George Smith, portfolio strategist for LPL Financial, historical data suggests that such sharp declines have often been followed by stronger-than-average returns.
LPL Financial says that since 1950, the S&amp;P 500 has experienced 608 single-day losses of more than 1.75%, averaging about eight occurrences per year. Despite their unsettling nature, these drops have historically presented buying opportunities.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a>
On average, the S&amp;P 500 has gained 1.5% one month after a 1.75% or greater daily loss, outperforming the historical one-month return of 0.7%. 
The outperformance extends over longer periods, with three-month, six-month, and one-year returns following such declines averaging 3.7%, 6.6%, and 12.2%, respectively—well above the historical averages of 2.2%, 4.5% and 9.2%. This suggests that while volatility remains a concern, past market patterns indicate a likelihood of recovery.
Price Action: As of Tuesday morning, the SPDR S&amp;P 500 ETF Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NASDAQ">SPY</a>) is down 3.6% for the week, trading at $574.54.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/bonds/25/03/44096578/leon-cooperman-says-he-likes-cash-calls-trumps-deficit-cutting-contractionary" target="_blank" rel="noreferrer noopener">Leon Cooperman Says He Likes Cash, Calls Trump's Deficit Cutting ‘Contractionary'</a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

ETFs

Stock Market Sell-Off: History Shows S&P 500 Rebounds After Big Drops

Chevron spokesperson Says It Is Aware Of U.S. President's Directive On Venezuela And Will Abide By Any Direction Given By U.S. Treasury Dept

Press Releases

Concentra Expands to DeSoto, Texas

Select Medical Holdings Corporation Announces Distribution Ratio for Special Stock Distribution to Stockholders

Mutual Funds

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Concentra Announces Completion of Spin-Off from Select Medical

Select Medical Holdings Corporation Completes Spin-Off of Concentra

Concentra Expands to Knoxville, Tennessee

Concentra Expands to Northlake, Texas

Concentra Announces Preliminary 2024 Financial Results, Agreement To Acquire Nova Medical Centers, and 2025 Financial Guidance

Concentra® to Announce Fourth Quarter and Full Year 2024 Results on Monday, March 3, 2025

Concentra Announces Fourth Quarter and Full Year 2024 Results and Closing of Nova Medical Centers Acquisition

Comments

Concentra Group Holdings

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL